News

FDA Upheaval Pushes Some Biotech Firms to Plan Early Trials Out of US
The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's ...
Feds recommend pausing vaccine for mosquito-borne disease chikungunya in people over 60
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
Clinical Trials Arena on MSN1d
EMA approves Moleculin’s application for Phase IIb/III AML trial
The European Medicines Agency (EMA) has approved Moleculin Biotech’s clinical trial application (CTA) for a pivotal, ...
Research raises concerns about the safety of long-term ADHD medication treatment in children
A recent study by the University of Turku and the University of Helsinki in Finland and the Finnish Social Insurance ...
BioPharma Dive2d
FDA follows EMA in limiting use of Valneva shot
Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...
MedPage Today on MSN5d
Drug Used by Trump Has Suicide Risk; FDA's 'Aggressive' AI Rollout; 1K Measles Cases
Thoughts of suicide was confirmed as a side effect of finasteride (Propecia, Proscar), the European Medicines Agency (EMA) ...
The Manila Times2d
Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin” or the "Company”), a late-stage pharmaceutical company with a broad ...
BioSpace2d
FDA, EU Flag Safety Issues With Valneva’s Chikungunya Vaccine
The FDA and CDC have also recommended pausing the use of Ixchiq in seniors 60 years and older while safety investigations are ...
Fierce Pharma2d
FDA, CDC call for pause of chikungunya shot rollout in older adults
On the heels of similar moves in France and the European Union, U.S. health authorities are calling for a pause in the use of ...
Sterilization Equipment Market to Surpass USD 18.44 Billion by 2032 as Hospitals and Labs Double Down on Infection Control – SNS Insider
Demand for reliable sterilization methods is climbing fast, driven by the surge in surgeries, rise in hospital-acquired infections, and tighter government oversight, says SNS Insider.Austin, May 14, ...